Both in Pharmaceuticals
Corvus Pharmaceuticals vs Alumis
Over the past year CRVS returned +26.3% and ALMS returned +39.9%; their daily moves had a correlation of 0.14.
CRVS +26.3% ALMS +39.9%Growth of $1, one year, split-adjusted
| Metric | CRVS | ALMS |
|---|---|---|
| Price | $9.70 | $6.38 |
| Market cap | $816.0M | $825.8M |
| Today | −3.29% | −5.20% |
| 1 month | −11.0% | −6.9% |
| 6 months | −39.5% | −74.7% |
| Year to date | +26.0% | −34.6% |
| 1 year | +25.0% | +36.9% |
| Revenue growth (YoY) | — | −37.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −8557.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 111.6× |
| Net cash | $215.2M | $502.3M |
| Dividend yield | — | — |
| Volatility (60d) | 51.9% | 180.3% |
| Short % of float | 25.5% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).